Beate Trojaneck

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

Ingo Schmidt‐Wolf, Sebastian Finke, Beate Trojaneck et al. · British Journal of Cancer · 1999 · 218 citations · Full text

Cytokine, Cik Cells, Cancer Immunosurveillance +15

Therapeutic Vaccination against Metastatic Carcinoma by Expression-Modulated and Immunomodified Autologous Tumor Cells: A First Clinical Phase I/II Trial

Burghardt Wittig, Angela Märten, Tomislav Dorbic et al. · Human Gene Therapy · 2001 · 86 citations

Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12

Birgit Zoll, Petja Lefterova, Markus Csipai et al. · Cancer Immunology Immunotherapy · 1998 · 67 citations · Full text

Inflammation, Cytokine, Autoimmune Disease +11

Lymphocyte apoptosis: induction by gene transfer techniques

Oliver Ebert, Sebastian Finke, André Salahi et al. · Gene Therapy · 1997 · 62 citations

Lymphocyte Development, Apoptosis, Immunology +7

Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene

Sebastian Finke, Beate Trojaneck, Petja Lefterova et al. · Gene Therapy · 1998 · 49 citations

Interleukin-7 Gene, Cancer Immunosurveillance, Antitumor Cytotoxicity +9